Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04120363 · ClinicalTrials.gov registry record · Phase 4
Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations
A Phase 4 study, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 34
- Enrollment target
NCT04120363: Completed Phase 4 study, sponsored by Pennington Biomedical Research Center.
NCT04120363 is a Phase 4 study that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 34 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04120363, a Phase 4 study, has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 34 participants
- Enrollment target
Study Summary
The objective of this study is to determine the effects of a single dose of testosterone undecanoate during and in recovery from simulated operational stress.
Primary Outcome
A load carriage time trial (a militarily relevant aerobic performance assessment) was conducted near the end of each study phase to assess aerobic performance.
Interventions
- DRUG Testosterone Undecanoate
- DRUG Sesame Oil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2019-09-23 |
| Est. Completion | 2021-07-08 |
| Phase | Phase 4 |
What the finished NCT04120363 record still lists
NCT04120363 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Testosterone Undecanoate is the first listed.
NCT04120363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04120363 about?
NCT04120363 is a clinical study titled "Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations". The objective of this study is to determine the effects of a single dose of testosterone undecanoate during and in recovery from simulated operational stress.
What is the current status of trial NCT04120363?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2019-09-23. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT04120363?
The interventions under investigation include: Testosterone Undecanoate (DRUG), Sesame Oil (DRUG).
Who is sponsoring clinical trial NCT04120363?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04120363's enrollment target sits among peer trials
34 1520th of 2000 higher than 473 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI